近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Kannangara DRW; Phipps-Green AJ; Dalbeth N; Stamp LK; Williams KM; Graham GG; Day RO; Merriman TR, 2016, 'Hyperuricaemia: Contributions of urate transporter ABCG2 and the fractional renal clearance of urate', Annals of the Rheumatic Diseases, vol. 75, no. 7, pp. 1363 - 1366, http://dx.doi.org/10.1136/annrheumdis-2015-208111 Chung WH; Chang WC; Stocker SL; Juo CG; Graham GG; Lee MHH; Williams KM; Tian YC; Juan KC; Wu YJJ; Yang CH; Chang CJ; Lin YJ; Day RO; Hung SI, 2015, 'Insights into the poor prognosis of allopurinol-induced severe cutaneous adverse reactions: The impact of renal insufficiency, high plasma levels of oxypurinol and granulysin', Annals of the Rheumatic Diseases, vol. 74, no. 12, pp. 2157 - 2164, http://dx.doi.org/10.1136/annrheumdis-2014-205577 Duong JK; Kumar SS; Furlong TJ; Kirkpatrick CM; Graham GG; Greenfield JR; Williams KM; Day RO, 2015, 'The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non-Indigenous Australians with type 2 diabetes mellitus', British Journal of Clinical Pharmacology, vol. 79, no. 4, pp. 617 - 623, http://dx.doi.org/10.1111/bcp.12525 Ghosh D; Williams KM; Graham GG; Nair P; Buscher H; Day RO, 2014, 'Multiple episodes of aspirin overdose in an individual patient: A case report', Journal of Medical Case Reports, pp. 1 - 5, http://dx.doi.org/10.1186/1752-1947-8-374 Duong JK; Furlong TJ; Roberts DM; Graham GG; Greenfield JR; Williams KM; Day RO, 2013, 'The role of metformin in metformin-associated lactic acidosis (MALA): Case series and formulation of a model of pathogenesis', Drug Safety, vol. 36, no. 9, pp. 733 - 746, http://dx.doi.org/10.1007/s40264-013-0038-6 Kannangara DRW; Ramasamy SN; Ray JE; Jones G; Graham GG; Williams KM; Day RO, 2013, 'An audit of a therapeutic drug monitoring service for allopurinol therapy', Therapeutic Drug Monitoring, vol. 35, no. 6, pp. 863 - 866, http://dx.doi.org/10.1097/FTD.0b013e318299920a Graham GG; Kannangara DRW; Stocker SL; Portek I; Pile KD; Indraratna PL; Datta I; Williams KM; Day RO, 2013, 'Understanding the dose-response relationship of allopurinol: Predicting the optimal dosage', British Journal of Clinical Pharmacology, vol. 76, no. 6, pp. 932 - 938, http://dx.doi.org/10.1111/bcp.12126 Duong JK; Kumar SS; Kirkpatrick CM; Greenup LC; Arora M; Lee TC; Timmins P; Graham GG; Furlong TJ; Greenfield JR; Williams KM; Day RO, 2013, 'Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: Simulation of doses according to renal function', Clinical Pharmacokinetics, vol. 52, no. 5, pp. 373 - 384, http://dx.doi.org/10.1007/s40262-013-0046-9 Day RO; Graham GG, 2013, 'Republished research: Non-steroidal anti-inflammatory drugs (NSAIDs)', British Journal of Sports Medicine, vol. 47, no. 17, pp. 1127, http://dx.doi.org/10.1136/bjsports-2013-f3195rep Ramasamy SN; Korb-Wells CS; Kannangara DRW; Smith MWH; Wang N; Roberts DM; Graham GG; Williams KM; Day RO, 2013, 'Allopurinol hypersensitivity: A systematic review of all published cases, 1950-2012', Drug Safety, vol. 36, no. 10, pp. 953 - 980, http://dx.doi.org/10.1007/s40264-013-0084-0 Day R; Lee H; Graham G; Williams K, 2013, 'Benzbromarone: Availability for general prescribing in New Zealand (a response to letters by Dr Lance Gravatt on benzbromarone)', New Zealand Medical Journal, vol. 126, no. 1382, pp. 124 - 126 Kannangara DRW; Graham GG; Williams KM; Day RO, 2013, 'Hypouricemic Effects of Prednisone and Allopurinol: An Uneven Playing Field?', Canadian Journal of Cardiology, http://dx.doi.org/10.1016/j.cjca.2013.04.015 Brett J; Chong O; Graham GG; Ray JE; Marriott D; Williams KM; Day RO, 2013, 'Antifungal use and therapeutic monitoring of plasma concentrations of itraconazole in heart and lung transplantation patients', Therapeutic Drug Monitoring, vol. 35, no. 1, pp. 133 - 136, http://dx.doi.org/10.1097/FTD.0b013e318275fe69 Graham GG; Davies MJ; Day RO; Mohamudally A; Scott KF, 2013, 'The modern pharmacology of paracetamol: Therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings', Inflammopharmacology: experimental and clinical studies, vol. 21, no. 3, pp. 201 - 232, http://dx.doi.org/10.1007/s10787-013-0172-x Day RO; Graham GG, 2013, 'Therapeutics: Non-steroidal anti-inflammatory drugs (NSAIDs)', BMJ-British Medical Journal, vol. 347, no. 7917, http://dx.doi.org/10.1136/bmj.f3195 Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs (NSAIDs).', BMJ-British Medical Journal, vol. 346, http://dx.doi.org/10.1136/bmj.f3195 Wong C; Kumar SS; Graham GG; Begg EJ; Chin P; Brett J; Ray J; Marriott D; Williams KM; Day RO, 2013, 'Comparing dose prediction software used to manage gentamicin dosing', Internal Medicine Journal, vol. 43, no. 5, pp. 519 - 525, http://dx.doi.org/10.1111/imj.12067 Stocker SL; Mclachlan AJ; Savic RM; Kirkpatrick CM; Graham GG; Williams KM; Day RO, 2012, 'The pharmacokinetics of oxypurinol in people with gout', British Journal of Clinical Pharmacology, vol. 74, no. 3, pp. 477 - 489, http://dx.doi.org/10.1111/j.1365-2125.2012.04207.x Kannangara DRW; Roberts DM; Furlong TJ; Graham GG; Williams KM; Day RO, 2012, 'Oxypurinol, allopurinol and allopurinol-1-riboside in plasma following an acute overdose of allopurinol in a patient with advanced chronic kidney disease', British Journal of Clinical Pharmacology, vol. 73, no. 5, pp. 828 - 829, http://dx.doi.org/10.1111/j.1365-2125.2011.04147.x Kannangara DRW; Ramasamy SN; Indraratna PL; Stocker SL; Graham GG; Jones G; Portek I; Williams KM; Day RO, 2012, 'Fractional clearance of urate: Validation of measurement in spot-urine samples in healthy subjects and gouty patients', Arthritis Research and Therapy, vol. 14, no. 4, http://dx.doi.org/10.1186/ar4020